By Carlo Martuscelli
Fresenius SE & Co. KGaA (FRE.XE) said Monday that it has acquired CediMed, a Colombian diagnostics group, in an investment totaling about 40 million euros ($44.7 million).
The deal was executed through Quironsalud, Fresenius's Spanish private hospital group, and is aimed at strengthening the company's presence in Latin America's health-care services market.
Fresenius said it expects to close the deal in the next few months.
Write to Carlo Martuscelli at firstname.lastname@example.org; @carlomartu